For a little over a year, the Office of Prescription Drug Promotion (OPDP) sent no untitled letters. OPDP ended this untitled letter hiatus this summer when it sent two untitled.
(BPT) - As the back-to-school season approaches, parents and caregivers of children with diabetes should review emergency plans for treating low blood sugar emergencies. With children spending a lot of
(BPT) - As the back-to-school season approaches, parents and caregivers of children with diabetes should review emergency plans for treating low blood sugar emergencies. With children spending a lot of
(BPT) - As the back-to-school season approaches, parents and caregivers of children with diabetes should review emergency plans for treating low blood sugar emergencies. With children spending a lot …
The wait is finally over. On June 7, 2023, after remaining silent for over an entire year, the US Food and Drug Administration ("FDA") Office of Prescription Drug Promotion ("OPDP") issued its first untitled.